CareDx - 10 Year Stock Price History | CDNA
- The all-time high CareDx stock closing price was 95.60 on January 20, 2021.
- The CareDx 52-week high stock price is 34.84, which is 54.3% above the current share price.
- The CareDx 52-week low stock price is 7.42, which is 67.1% below the current share price.
- The average CareDx stock price for the last 52 weeks is 16.69.
CareDx Historical Annual Stock Price Data | ||||||
---|---|---|---|---|---|---|
Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
2024 | 17.3410 | 11.9400 | 33.9900 | 7.5600 | 22.5800 | 88.17% |
2023 | 9.6327 | 11.1000 | 17.6100 | 4.9000 | 12.0000 | 5.17% |
2022 | 25.6693 | 46.6000 | 46.6000 | 10.8800 | 11.4100 | -74.91% |
2021 | 71.2634 | 71.4900 | 95.6000 | 41.2000 | 45.4800 | -37.23% |
2020 | 35.7752 | 21.1500 | 77.0900 | 13.9400 | 72.4500 | 235.88% |
2019 | 27.9135 | 23.9800 | 40.0800 | 19.2400 | 21.5700 | -14.20% |
2018 | 15.5675 | 7.0500 | 30.0200 | 5.1800 | 25.1400 | 242.51% |
2017 | 2.9090 | 2.3000 | 7.3700 | 0.7857 | 7.3400 | 171.85% |
2016 | 4.4480 | 6.2700 | 6.3300 | 2.6500 | 2.7000 | -57.81% |
2015 | 6.0152 | 7.2250 | 7.6700 | 4.1100 | 6.4000 | -11.72% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $1.241B | $0.280B |
CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of transplant surveillance, such as the use of cell-free DNA (cfDNA) as a biomarker for rejection. CareDx, Inc. is based in Brisbane, California. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Elevance Health (ELV) | United States | $93.361B | 11.58 |
Cencora (COR) | United States | $48.280B | 17.81 |
DiDi Global (DIDIY) | China | $22.212B | 0.00 |
Natera (NTRA) | United States | $22.082B | 0.00 |
ICON (ICLR) | Ireland | $17.675B | 15.74 |
Viatris (VTRS) | United States | $15.958B | 4.92 |
Avantor (AVTR) | United States | $14.143B | 21.20 |
Revvity (RVTY) | United States | $13.634B | 23.68 |
CochLear (CHEOY) | Australia | $12.777B | 0.00 |
Solventum (SOLV) | United States | $12.233B | 0.00 |
BioMerieux (BMXMF) | France | $11.895B | 0.00 |
Medpace Holdings (MEDP) | United States | $10.498B | 29.58 |
Charles River Laboratories (CRL) | United States | $10.011B | 19.34 |
HealthEquity (HQY) | United States | $9.104B | 49.41 |
Doximity (DOCS) | United States | $8.999B | 52.97 |
Sonic Healthcare (SKHHY) | Australia | $8.862B | 0.00 |
Bausch + Lomb (BLCO) | Canada | $6.892B | 32.08 |
Life Times (LTH) | United States | $5.081B | 33.63 |
Organon (OGN) | United States | $3.935B | 3.97 |
Sotera Health (SHC) | United States | $3.631B | 19.42 |
BrightSpring Health Services (BTSG) | United States | $3.265B | 69.44 |
Surgery Partners (SGRY) | United States | $2.925B | 33.35 |
Concentras Parent (CON) | United States | $2.789B | 0.00 |
PACS (PACS) | United States | $2.515B | 0.00 |
Alignment Healthcare (ALHC) | United States | $2.310B | 0.00 |
Ardent Health Partners (ARDT) | United States | $2.259B | 0.00 |
Premier (PINC) | United States | $2.195B | 11.42 |
GeneDx Holdings (WGS) | United States | $2.162B | 0.00 |
Ryman Healthcare (RYHTY) | New Zealand | $1.995B | 0.00 |
GoodRx Holdings (GDRX) | United States | $1.868B | 49.00 |
Teladoc Health (TDOC) | United States | $1.828B | 0.00 |
Progyny (PGNY) | United States | $1.315B | 26.62 |
Pediatrix Medical (MD) | United States | $1.285B | 12.57 |
Establishment Labs Holdings (ESTA) | $1.206B | 0.00 | |
AMN Healthcare Services Inc (AMN) | United States | $0.984B | 6.66 |
Embecta (EMBC) | United States | $0.797B | 5.32 |
QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
Agilon Health (AGL) | United States | $0.779B | 0.00 |
SBC Medicals (SBC) | United States | $0.674B | 0.00 |
InnovAge Holding (INNV) | United States | $0.662B | 0.00 |
Auna S.A (AUNA) | Luxembourg | $0.522B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.474B | 0.00 |
DocGo (DCGO) | United States | $0.434B | 16.35 |
Enhabit (EHAB) | United States | $0.380B | 32.87 |
COMPASS Pathways (CMPS) | United Kingdom | $0.302B | 0.00 |
ModivCare (MODV) | United States | $0.254B | 13.79 |
LifeMD (LFMD) | United States | $0.251B | 0.00 |
Sera Prognostics (SERA) | United States | $0.221B | 0.00 |
Biodesix (BDSX) | United States | $0.186B | 0.00 |
Nutex Health (NUTX) | United States | $0.179B | 0.00 |
Beauty Health (SKIN) | United States | $0.176B | 0.00 |
MultiPlan (MPLN) | United States | $0.112B | 0.00 |
So-Young (SY) | China | $0.086B | 16.60 |
Ascend Wellness Holdings (AAWH) | United States | $0.085B | 0.00 |
Singular Genomics Systems (OMIC) | United States | $0.054B | 0.00 |
OncoCyte (OCX) | United States | $0.046B | 0.00 |
NeueHealth (NEUE) | United States | $0.041B | 1.10 |
IceCure Medical (ICCM) | Israel | $0.032B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.032B | 0.00 |
Pheton Holdings (PTHL) | China | $0.031B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.021B | 0.00 |
Oncology Institute (TOI) | United States | $0.012B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
XWELL (XWEL) | United States | $0.008B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
KindlyMD (KDLY) | United States | $0.006B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
ISpecimen (ISPC) | United States | $0.004B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
Aclarion (ACON) | United States | $0.002B | 0.00 |
Cano Health (CANOQ) | United States | $0.001B | 0.00 |